Oncology

Latest News

Tech Updates: McKesson Launches Precision Oncology Consortium; Financing for RISA Labs PA Platform

By Mary Caffrey

April 17th 2025

These advances are designed to improve uptake of biomarker-driven cancer care and reduce treatment delays.

Making Novel Cancer Therapies Available Requires Choices Because Resources Are Limited

By Kyle Munz

April 14th 2025

Businessman shows medical network wooden block for health, medicine, insurance, healthcare, care, concept. Medical technology services to solve public - ภัทรชัย รัตนชัยวงค์ - stock.adobe.com.jpeg

NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer

By Giuliana Grossi

April 9th 2025

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

By Galen Shearn-Nance, BS
Rishi R. Sachdev, BS

April 4th 2025

Woman with keloid on shoulder | Image credit: weerajata – stock.adobe.com

Deep Learning Tool Differentiates Keloids From Malignant Lesions Without Dermoscopy

By Hayden E. Klein

April 2nd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

June 28th 2018

Dr Jamie Bakkum-Gamez on Developing an Early Detection Test for Endometrial Cancer

Jamie Bakkum-Gamez, MD, associate professor of obstetrics and gynecology and Gynecologic oncologist at Mayo Clinic, discusses her research on developing an early detection test for endometrial cancer.

June 28th 2018

Tecentriq–Chemotherapy Combination Demonstrates Increased Survival in ES-SCLC

Samantha DiGrande

This week, drug maker Roche released positive data from its phase 3 IMpower133 study that investigated an immunotherapy-based combination of atezolizumab (Tecentriq) and chemotherapy in the treatment of extensive-stage small cell lung cancer (ES-SCLC).

June 27th 2018

Evidence-Based OncologyTM, an AJMC® Publication, Explores the Rise of Technology at the Point of Care

From the role of data in treatment decisions to the use of apps in tracking patient responses, technology is now front-and-center in cancer care. A special issue of Evidence-Based Oncology™, a publication of The American Journal of Managed Care®, explores the rise of point-of-care tools.

June 27th 2018

Mutation in T-Cell ALL Enables Cancer Cells to Survive Chemotherapy

Laura Joszt, MA

Cancer cells can take advantage of the BCL-2 protein to survive chemotherapy, but a drug that suppresses BCL-2 may have promise in patients with leukemia who produce too much of the protein.

June 27th 2018

Exploring the Current State of Precision Medicine at the ASCO Annual Meeting

During this year's American Society of Clinical Oncology (ASCO) annual meeting, we sat down with 4 physicians to discuss their experiences with precision medicine, how it's changing oncology care, challenges associated with the shift, and where they think the future of precision medicine is headed.

June 26th 2018

Dr Victoria Villaflor Discusses How Novel Therapies Have Changed Cancer Treatment

Immune therapies, or check point inhibitors, have been very successful in a subset of patient with multiple different types of malignancies and has changed their trajectory tremendously, explained Victoria Villaflor, MD, associate professor of Medicine, hematology and oncology, Northwestern University.

June 26th 2018

Radiation Oncologists Take to Capitol Hill to Emphasize Importance of Specialty APM

Laura Joszt, MA

As radiation oncologists met with policy makers in Congress as part of the 15th annual American Society of Radiation Oncology Advocacy Day, the need for a radiation oncology–specific alternative payment model (APM) was one of the key topics of discussion.

June 25th 2018

Immunotherapy-Based Combination Improves Survival in SCLC for First Time in Phase 3 Study

Jaime Rosenberg

First-line treatment with atezolizumab plus chemotherapy helped patients with previously untreated extensive-stage small cell lung cancer (SCLC) live significantly longer than those treated with chemotherapy alone.

June 25th 2018

Gottlieb Calls on Payers to Share Data to Aid Drug Innovation

Mary Caffrey

During remarks at the National Comprehensive Cancer Network Policy Conference, FDA Commissioner Scott Gottlieb, MD, called for more data sharing and explained how the FDA is working to modernize the clinical trial process.

$ELOQUENT-3 Meets Its Primary End Point in Treating Relapsed/Refractory Multiple Myeloma$

June 24th 2018

ELOQUENT-3 Meets Its Primary End Point in Treating Relapsed/Refractory Multiple Myeloma

Kelly Davio

During the European Hematology Association’s 23rd Congress, held from June 14 to 17 in Stockholm, Sweden, researchers announced that the ELOQUENT-3 phase 2 study, evaluating elotuzumab with pomalidomide and low-dose dexamethasone in patients with relapsed/refractory multiple myeloma, met its primary endpoint in showing a statistically significant, clinically meaningful improvement in progression-free survival.

June 23rd 2018

Podcast: This Week in Managed Care—Creating Association Health Plans and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

June 23rd 2018

Joslin Diabetes Center, The American Journal of Managed Care® Collaborate to Publish Clinical Guidelines

Clinical guidelines that direct care at Joslin Diabetes Center, the world-renowned institution for diabetes treatment, research, and education, are now published in Evidence-Based Diabetes Management™, a publication of The American Journal of Managed Care®

June 22nd 2018

This Week in Managed Care: June 22, 2018

This week in managed care, the top stories included Atul Gawande, MD, being named the CEO of the Amazon–Berkshire Hathaway–JPMorgan Chase healthcare venture; the Trump administration finalized rules for creating association health plans; an analysis found some cancer types are represented more than others in the Oncology Care Model.

June 22nd 2018

AJMC® in the Press, June 22, 2018

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

June 22nd 2018

Patients With Myelofibrosis Treated With JAK1/2 Inhibitors at Increased Risk of Lymphomas

Laura Joszt, MA

Patients with myelofibrosis who were treated with Janus-kinase (JAK) 1/2 inhibitors have an increased risk for developing B-cell lymphoma. However, researchers believe there is a pre-existing B-cell clone that patients can be tested for before treatment.

June 21st 2018

FDA Warns Efficacy Concerns in Some Patients Taking Keytruda, Tecentriq

Samantha DiGrande

In a statement released yesterday, the FDA has announced that it is restricting the use of pembrolizumab (Keytruda) and atezolizumab (Tecentriq) for patients with locally advanced or metastatic urothelial cancer who are not eligible for cisplatin-containing therapy.

June 21st 2018

Dr Peter Paul Yu: How Next-Generation Sequencing Is Changing Cancer Care

Next-generation sequencings tests are just starting to change the landscape for cancer patients, explained Peter Paul Yu, MD, FASCO, FACP, physician-in-chief, Hartford HealthCare Cancer Center.

June 21st 2018

TAILORx Results May Mitigate Financial Toxicity

Molly MacDonald

TAILORx is very good news for an estimated 60,000 women a year, who in years past would have received chemotherapy, possibly risking long-term physical and mental side effects, in addition to experiencing what is now an additional and recognized side effect of cancer treatment: financial toxicity.

June 21st 2018

Viral Suppression in People With HIV Associated With Reduced Cancer Risk

Jaime Rosenberg

For people living with HIV who achieve viral suppression from antiretroviral therapy, there is a reduced risk of developing both AIDS-defining cancer and non-AIDS-defining cancer.

June 20th 2018

Center for HOPE: Addressing Health Needs and Cancer Disparities Among Underserved Populations

Last month, the Huntsman Cancer Institute at the University of Utah announced the opening of the Huntsman Center for Health Outcomes and Population Equity (HOPE). The research and clinical center is dedicated to preventing cancer and improving health among underserved populations.

June 20th 2018

Recent-Onset Diabetes May Be a Sign of Pancreatic Cancer in African American, Latino Adults

Kelly Davio

While receiving a diagnosis of type 2 diabetes is common for US adults, African American and Latino adults over age 50 who receive a new diabetes diagnosis may have another health issue to be concerned about: pancreatic cancer.

June 20th 2018

Nivolumab Gains First Indication in China for NSCLC

Samantha DiGrande

Last week, Bristol-Myers Squibb announced that the China National Drug Administration approved the country’s first immuno-oncology and first PD-1 therapy, nivolumab (Opdivo), for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).

June 20th 2018

Medical World News: Clinical Updates, June 2018

Jaime Rosenberg Laura Joszt, MA

Coverage of the latest clinical updates in cancer research.

June 20th 2018

Participation in OCM May Transform Care for Certain Cancer Types More Quickly Than Others

Laura Joszt, MA

Physicians participating in the Oncology Care Model now provider care for approximately 21% of Medicare patients with cancer. An analysis from Avalere Health found that those doctors treat some types of cancers more than others.

June 19th 2018

Population Health Council Discusses Progress in Payment Reform, Ongoing Barriers in Oncology Care

Mary Caffrey

Lessons from the first meeting of The American Journal of Managed Care® Population Health Council.

June 19th 2018

With the Oncology Care Model, "Everyone Has to Be Engaged," Including Patients

Mary Caffrey

AJMC® Convenes First Gathering of Institute for Value-Based Medicine to Share Best Practices in New Payment Models in Cancer Care

June 19th 2018

Quizartinib Prolongs Overall Survival in Deadly Form of AML Compared With Chemotherapy

Laura Joszt, MA

An investigational drug has prolonged survival in patients with a rare and deadly form of acute myeloid leukemia (AML).

June 19th 2018

Perspective: FDA/CMS Parallel Review Advances Coverage for Cancer Comprehensive Genomic Profiling

Lakshman Ramamurthy, PhD Kristi Maxwell, MS, CGC Bethany Sawchyn, PharmD Rachel Anhorn, PharmD

Authors from Foundation Medicine explain the regulatory path that led to approval of FoundationOne CDx.

June 19th 2018

From the Editor in Chief: Making Disruptive Technology Less Disruptive

Joseph Alvarnas, MD

Film is truth 24 times a second, and every cut is a lie – Jean-Luc Godard

June 19th 2018

A Retrospective on the Oncology Care Model

Ryan Holleran Arif Gilani Abigail Orlando Brenton Fargnoli, MD

Flatiron Health recently conducted a retrospective review of the Oncology Care Model, discovering what's working, what isn't, and what this could mean for the future.

...

43 44 45 46 47 48 49 50 51

...

184 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions